Biosimilar insulins: how similar is similar?

Biosimilar insulins: how similar is similar?

Item
http://www.wikidata.org/entity/Q35337749
The emergence of biosimilar insulin preparations--a cause for concern?Biosimilar Insulins: Basic ConsiderationsBiosimilar Insulin and Costs: What Can We Expect?Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.Biosimilar insulins.Ultrafast-acting insulins: state of the artThe biosimilar insulin landscape: current developments.Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody.Biologicals and biosimilars: safety issues in Europe.The process defines the product: what really matters in biosimilar design and production?Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.
P2860

Biosimilar insulins: how similar is similar?

Item
http://www.wikidata.org/entity/Q35337749
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biosimilar insulins: how similar is similar?
@ast
Biosimilar insulins: how similar is similar?
@en
type
label
Biosimilar insulins: how similar is similar?
@ast
Biosimilar insulins: how similar is similar?
@en
prefLabel
Biosimilar insulins: how similar is similar?
@ast
Biosimilar insulins: how similar is similar?
@en
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Biosimilar insulins: how similar is similar?
@en
P2860
P304
P31
P356
10.1177/193229681100500329
P433
P478
P50
P577
P5875
P698
P932